Management

Treatment for dicarboxylic aminoaciduria is centred around managing the signs and symptoms and any complication that may develop. These may include, among others, kidney stones, fasting hypoglycemia, seizures, and neuropsychiatric manifestations. At this time, there is no data indicating specific clinical management for individuals with homozygous or heterozygous loss of function variants or deletions of SLC1A1.